Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: Potential targets of BAL development

Blood

Volumn 120, Issue 18, 2012, Pages 3688-3698

  Simmons, Szandor ^a,b   Knoll, Marko ^a   Drewell, Christopher ^a   Wolf, Ingrid ^a   Mollenkopf, Hans Joachim ^a   Bouquet, Corinne ^a   Melchers, Fritz ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; DOXYCYCLINE; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR PAX5;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BIPHENOTYPIC CELL; BONE MARROW CELL; CD19- B220+ CD11B+ T LYMPHOCYTE; CELL CLONE; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION; GENETIC TRANSDUCTION; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84868570701     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-414821     Document Type: Article

References (50)

1. Fuxa M, Busslinger M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J Immunol. 2007;178(12):8222-8228.
2. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss-and gain-of-function experiments. EMBO J. 1998; 17(8):2319-2333. (Pubitemid 28171916)
3. Schebesta M, Pfeffer PL, Busslinger M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity. 2002;17(4):473-485. (Pubitemid 35223536)
4. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999; 401(6753):556-562.
5. Souabni A, Cobaleda C, Schebesta M, Busslinger M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity. 2002; 17(6):781-793. (Pubitemid 35477797)
6. Schebesta A, McManus S, Salvagiotto G, Delogu A, Busslinger GA, Busslinger M. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity. 2007;27(1):49-63. (Pubitemid 47096800)
7. Tagoh H, Ingram R, Wilson N, et al. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction. EMBO J. 2006;25(5):1070-1080. (Pubitemid 43372120)
8. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity. 2006;24(3):269-281.
9. Holmes ML, Carotta S, Corcoran LM, Nutt SL. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 2006;20(8): 933-938.
10. Mikkola I, Heavey B, Horcher M, Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science. 2002;297(5578):110-113. (Pubitemid 34743105)
11. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell. 1994; 79(5):901-912. (Pubitemid 24371980)
12. Rolink AG, Nutt SL, Melchers F, Busslinger M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature. 1999;401(6753):603-606.
13. Schaniel C, Gottar M, Roosnek E, Melchers F, Rolink AG. Extensive in vivo self-renewal, longterm reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood. 2002;99(8):2760-2766. (Pubitemid 34525363)
14. Cook JR, Aguilera NI, Reshmi-Skarja S, et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol. 2004;35(4):447-454. (Pubitemid 38507081)
15. Poppe B, De Paepe P, Michaux L, et al. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. Genes Chromosomes Cancer. 2005; 44(2):218-223. (Pubitemid 41306651)
16. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia. 2007;21(6):1258-1266. (Pubitemid 46831815)
17. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-764. (Pubitemid 46582031)
18. An Q, Wright SL, Konn ZJ, et al. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci U S A. 2008;105(44):17050-17054.
19. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007; 449(7161):473-477. (Pubitemid 47509547)
20. Heltemes-Harris LM, Willette MJ, Ramsey LB, et al. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia. J Exp Med. 2011;208(6):1135-1149.
21. Bouquet C, Melchers F. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes. Eur J Immunol. 2012; 42(2):522-532.
22. Baum C, Dullmann J, Li Z, et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood. 2003;101(6):2099-2114. (Pubitemid 36302043)
23. Nutt SL, Urbanek P, Rolink A, Busslinger M. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 1997;11(4): 476-491. (Pubitemid 27097646)
24. Rolink A, Kudo A, Karasuyama H, Kikuchi Y, Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J. 1991;10(2):327-336. (Pubitemid 21905482)
25. Vegh P, Winckler J, Melchers F. Long-term "in vitro" proliferating mouse hematopoietic progenitor cell lines. Immunol Lett. 2010;130(1-2):32-35.
26. Nutt SL, Vambrie S, Steinlein P, et al. Independent regulation of the two Pax5 alleles during B-cell development. Nat Genet. 1999;21(4):390-395. (Pubitemid 29159575)
27. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol. 2004;22:55-79. (Pubitemid 38680418)
28. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998;18(7):4301-4314. (Pubitemid 28287953)
29. Reddy VA, Iwama A, Iotzova G, et al. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood. 2002;100(2):483-490. (Pubitemid 34761110)
30. Feng R, Desbordes SC, Xie H, et al. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A. 2008;105(16):6057-6062. (Pubitemid 351758398)
31. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloidcommitted progenitors to Flt3+ dendritic cells in vivo. J Exp Med. 2003;198(2):305-313. (Pubitemid 36987855)
32. Izon D, Rudd K, DeMuth W, et al. A common pathway for dendritic cell and early B cell development. J Immunol. 2001;167(3):1387-1392. (Pubitemid 32703136)
33. Dannaeus K, Johannisson A, Nilsson K, Jonsson JI. Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes. Exp Hematol. 1999;27(11): 1646-1654. (Pubitemid 29526749)
34. Cumano A, Paige CJ, Iscove NN, Brady G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature. 1992;356(6370):612-615.
35. Balciunaite G, Ceredig R, Massa S, Rolink AG. A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur J Immunol. 2005;35(7):2019-2030. (Pubitemid 41015041)
36. Rolink A, ten Boekel E, Melchers F, Fearon DT, Krop I, Andersson J. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J Exp Med. 1996;183(1):187-194. (Pubitemid 26028758)
37. Anderson K, Rusterholz C, Mansson R, et al. Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes. Blood. 2007;109(9):3697-3705. (Pubitemid 46641718)
38. Tiacci E, Pileri S, Orleth A, et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8; 21)-acute myelogenous leukemia. Cancer Res. 2004;64(20):7399-7404. (Pubitemid 39372080)
39. Zhang X, Lin Z, Kim I. Pax5 expression in non-Hodgkin's lymphomas and acute leukemias. J Korean Med Sci. 2003;18(6):804-808. (Pubitemid 38072929)
40. Torlakovic E, Slipicevic A, Robinson C, et al. Pax-5 expression in nonhematopoietic tissues. Am J Clin Pathol. 2006;126(5):798-804. (Pubitemid 44707631)
41. Dong HY, Liu W, Cohen P, Mahle CE, Zhang W. B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas. Am J Surg Pathol. 2005;29(5):687-692. (Pubitemid 40577881)
42. Babjuk M, Soukup V, Mares J, et al. The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome. Int Urol Nephrol. 2002; 34(4):495-501. (Pubitemid 37235974)
43. Killick S, Matutes E, Powles RL, et al. Outcome of biphenotypic acute leukemia. Haematologica. 1999;84(8):699-706. (Pubitemid 29424405)
44. Legrand O, Perrot JY, Simonin G, et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol. 1998;100(1):147-155. (Pubitemid 28051853)
45. Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia. Haematologica. 1997;82(1):64-66. (Pubitemid 28023490)
46. Caudell D, Zhang Z, Chung YJ, Aplan PD. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res. 2007;67(17): 8022-8031. (Pubitemid 47395136)
47. Driever W, Nusslein-Volhard C. The bicoid protein determines position in the Drosophila embryo in a concentration-dependent manner. Cell. 1988; 54(1):95-104.
48. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L. Dynamic regulation of PU. 1 expression in multipotent hematopoietic progenitors. J Exp Med. 2005; 201(2):221-231. (Pubitemid 40189431)
49. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU. 1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201(9):1487-1502. (Pubitemid 40664092)
50. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU. 1. Science. 2000;288(5470):1439-1441.